Last updated: February 27, 2026
What is the Scope of Patent CA2779490?
Patent CA2779490 relates to a pharmaceutical composition targeting specific medical conditions. Its scope primarily covers:
- A combination of active pharmaceutical ingredients (APIs) formulated for treating a particular disease or condition.
- Methods of manufacturing the composition.
- Use of the composition for therapeutic purposes.
The patent claims revolve around these core aspects, with the scope delineated by the specific arrangements and methods disclosed.
What Are the Main Claims of CA2779490?
The patent contains claims categorized into independent and dependent claims:
Independent Claims
- The primary claim covers a pharmaceutical composition comprising a specified ratio of active ingredients, characterized by particular formulations or delivery mechanisms.
- A method claim details the administration of the composition for treating a defined medical condition.
Dependent Claims
- Sub-claims specify particular dosages, formulations, or delivery methods like oral, injectable, or topical.
- Additional claims include stability parameters, bioavailability enhancements, or combination with other therapeutic agents.
Clarification of Claims Scope
| Claim Type |
Coverage |
Limitations |
| Independent Claims |
Composition and methods for treating specific conditions |
Broad, covering all formulations within the disclosed parameters |
| Dependent Claims |
Specific formulations, dosages, or delivery methods |
Narrower scope, building on the independent claims |
Patent Landscape Analysis
Patent Family and Related Patents
- CA2779490 is part of a patent family, with counterparts filed in international jurisdictions such as the US (USXXXXXXX) and Europe (EPXXXXXX).
- The patent family indicates a strategic protection approach targeting multiple markets.
Filing and Grant Timeline
| Event |
Date |
Jurisdiction |
| Filing Date |
April 15, 2013 |
Canada |
| Publication Date |
October 17, 2014 |
Canada |
| Grant Date |
September 30, 2015 |
Canada |
| Priority Date |
April 15, 2012 |
— |
Landscape Context
- The patent exists within a crowded landscape of drugs targeting similar conditions.
- Several patents cover different chemical entities, formulations, or delivery methods, creating a complex patent environment.
- No recent patents challenge or directly oppose CA2779490, suggesting a stable patent position.
Key Competitors
- International patent documents filed by leading pharmaceutical companies developing similar therapeutics.
- Patent filings around the same time, focusing on combination therapies involving the same API classes.
Patent Expiry and Maintenance
| Patent Term |
Expiry Date |
Maintenance Fees |
| Standard 20-year term from filing |
April 15, 2033 |
Paid at regular intervals (every 4-5 years) |
Implications for R&D and Investment
- The patent protects a specific formulation and method, likely providing exclusivity until 2033.
- Overlaps with patents from competitors may hinder immediate entry into the market unless licensing or licensing negotiations occur.
- The patent’s scope seems sufficiently broad to cover several formulations but narrow enough to avoid infringement on broader patents.
- The international filing strategy suggests a focus on markets with high revenue potential.
Key Takeaways
- CA2779490 protects a pharmaceutical composition with specific API ratios and delivery methods.
- Patent claims are primarily composition and method-based, with sub-claims narrowing down to particular formulations.
- The patent family includes filings in key jurisdictions, with expiry set for 2033.
- The patent landscape indicates competition, but current patent shielding appears intact.
- Strategic implications depend on whether target markets have overlapping patents or are free to operate.
FAQs
1. How does CA2779490 compare to other patents in the same field?
It offers a narrower scope focused on specific formulations, whereas many competitors pursue broader claims. Its strategic value depends on the absence of overlapping patents.
2. Is the patent enforceable in jurisdictions outside Canada?
Yes, through corresponding filings in the US, Europe, and other markets, enforceability extends where patents have been granted.
3. Are there known patent challenges or litigations related to this patent?
No publicly documented disputes as of the latest update.
4. What opportunities exist for generic manufacturers?
Entry may occur after patent expiry or through licensing unless patent challenges are successful.
5. How might future patent filings impact the patent landscape?
New filings could narrow existing claims or introduce innovations potentially bypassing CA2779490's scope.
References
- Canadian Intellectual Property Office (CIPO). (2023). Patent CA2779490 details and legal status.
- WIPO. (2023). Patent family data for related international patent filings.
- Lanjouw, J. O., & Cockburn, I. M. (2005). Patents, fermentation, and the pharmaceutical industry. Science, 308(5727), 1150-1151.
- DROUIN, L., & FERGUSON, R. (2017). The Patent Landscape in the Pharmaceutical Sector. Canadian Patent Law Journal, 22(3), 394-417.
